Explore evidence

22.41 %Malaria prevalence from all Plasmodium species was 22.41% in active screening.

Malipaludismepublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations

79.5 %In the COVID-19 sample group (N = 266), the prevalence of antibody responders against S was 79.5% among males and 81.7% among females.

MaliCOVID-19 · SARS-CoV-2 S proteinHAL · Unilimdocument of 67 observations

81.67 %SickleScan® had a sensitivity of 81.67% [95% CI: 71.88–91.46] for diagnosing major sickle cell disease (SCD) compared to high-performance liquid chromatography in a study in Mali, April–August 2021.

Malidrépanocytoseobserved April–August 2021HAL · Unilimdocument of 103 observations

97.2 %Proportions of 24H microscopy positive patients in Faladje and Bougoula-Hameau were 97.2% and 72%, respectively.

Malipaludismepublished 2020International journal of infectious diseases : IJID : official publication of the Internateurope_pmcdocument of 4 observationsDOI 10.1016/j.ijid.2020.03.082

69.8 %La fréquence de la neuropathie polyneuropathique diabétique était de 69,8 % chez 252 patients hospitalisés au Mali en 2020.

Malineuropathie polyneuropathique diabétiqueobserved 2020HAL · Unilimdocument of 747 observations

2.35 per_1000_person_weeksFrom May 2024 to February 2025, children aged 1–4 years had 2.35 uncomplicated malaria cases per 1,000 person-weeks in the Kidal region.

Malipaludismeobserved 2024-2025HAL · Unilimdocument of 80 observations

44.5 %In a matched case-control study of 567 Malian children, blood group O was present in 44-45% of uncomplicated malaria controls and healthy controls.

Malipaludismepublished 2007Proceedings of the National Academy of Sciences of the United States of Americaeurope_pmcdocument of 4 observations

80.5 %Recognition of the SARS-CoV-2 proteins by sera from COVID-19 patients was 80.5% for S, 71.1% for RBD, and 31.9% for RBM.

MaliCOVID-19HAL · Unilimdocument of 67 observations

76.2 %The frequency of the pfcrt 76T mutation in Plasmodium falciparum was 76.2% (128/168) before treatment.

Malipaludismepublished 2021The Journal of parasitologyeurope_pmcdocument of 8 observations

23 %The proportion of gametocyte carriers was 23% at baseline and 24% on day 7 in the 2010–2011 study.

Malipaludismeobserved 2010-2011published 2016Parasite (Paris, France)europe_pmcdocument of 5 observationsDOI 10.1051/parasite/2016003

98.5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 98.5% showed a 10-fold increase in anti-CSP IgG antibody titres post-2017 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2017HAL · Unilimdocument of 105 observations

Malaria infection increased levels of antibodies to malaria antigens.

Malipaludismepublished 2015Malaria journaleurope_pmcdocument of 3 observations

12 g/dLHemoglobin levels < 12 g/dL were observed only in homozygous SCD patients.

Malidrépanocytosepublished 2024Hemoglobineurope_pmcdocument of 9 observations

71.9 %The RBD showed comparable antibody responses of 71.9% to the full-length S protein, which had an antibody response of 80.5%.

MaliCOVID-19HAL · Unilimdocument of 67 observations

72 %Parmi les 157 patients fébriles ayant reçu des soins d'agents de santé communautaires, 113 (72 %) ont été testés positifs pour le paludisme et ont ensuite reçu un traitement antipaludique.

MalipaludismeHAL · Unilimdocument of 36 observations

13 %Entre 2016 et 2019, les cas de paludisme au Mali ont diminué de 13 %, passant de 384 à 334 pour 1000 habitants.

Malipaludismeobserved 2016 à 2019HAL · Unilimdocument of 214 observations

31 %Pericopsis laxiflora était utilisé principalement contre les douleurs externes avec une fréquence d'utilisation de 31 %.

Malidouleurs externesHAL · Unilimdocument of 20 observations

Patients who received artemether-lumefantrine and were qPCR positive at 72 hours were significantly more likely to have microscopically detectable recurrent Plasmodium falciparum parasitemia by day 42 than those receiving other regimens.

Malipaludismepublished 2021Antimicrobial agents and chemotherapyeurope_pmcdocument of 2 observations

36 %36% of individuals in the PIP profile avoided seeing friends.

MaliCOVID-19HAL · Unilimdocument of 88 observations

The incidence rate of clinical malaria varied significantly from June 2009 to July 2013 without a clear downward trend in Bandiagara, Mali.

Malipaludismeobserved June 2009 to July 2013published 2014Malaria journaleurope_pmcdocument of 3 observationsDOI 10.1186/1475-2875-13-374

30 msUn patient porteur des variations rs2116964399 et NM_000238.4:c.1604T > A a présenté une prolongation de l'intervalle QTc de 30 ms après 2 jours de traitement par DHA-PQ.

Maliprolongation de l'intervalle QTcHAL · Unilimdocument of 62 observations

1 %Following first treatment, 13 (1%) of 996 patients had hepatotoxicity.

Malipaludismepublished 2016The Lancet. Infectious diseaseseurope_pmc

18 %After seasonal malaria chemoprevention (SMC), parasitaemia prevalence fell to 18% in the intervention district.

Maliparasitemiaobserved December 2014published 2017Malaria journaleurope_pmcdocument of 10 observations

37 %Le paludisme représentait 37 % des motifs de consultation en 2021 au Mali.

Malipaludismeobserved 2021HAL · Unilimdocument of 214 observations

135.11 mmSustained heavy rainfall of 135.11 mm occurred over 15 weeks during the 2024 malaria outbreak in the Kidal region.

Malipaludismeobserved 2024HAL · Unilimdocument of 80 observations